Detalhe da pesquisa
1.
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.
Biochem J
; 479(9): 1007-1030, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470373
2.
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure.
MAbs
; 15(1): 2163459, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36628468
3.
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII.
J Thromb Haemost
; 19(11): 2710-2725, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333849
4.
FVIII half-life extension by coadministration of a D'D3 albumin fusion protein in mice, rabbits, rats, and monkeys.
Blood Adv
; 4(9): 1870-1880, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374879